WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
1. (WO2014022720) POLYMER CONJUGATES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/022720    International Application No.:    PCT/US2013/053314
Publication Date: 06.02.2014 International Filing Date: 01.08.2013
IPC:
A61K 47/48 (2006.01), A61K 47/30 (2006.01), A61K 48/00 (2006.01)
Applicants: CARNEGIE MELLON UNIVERSITY [US/US]; 5000 Forbes Avenue Pittsburgh, PA 15213 (US).
DAS, Subha, Ranjan [--/US]; (US).
PAREDES, Eduardo [US/US]; (US).
AVERICK, Saadyah [US/US]; (US).
MATYJASZEWSKI, Krzysztof [US/US]; (US)
Inventors: DAS, Subha, Ranjan; (US).
PAREDES, Eduardo; (US).
AVERICK, Saadyah; (US).
MATYJASZEWSKI, Krzysztof; (US)
Agent: BARTONY, Henry, E., Jr.; Bartony & Associates, LLC P.O. Box 910 Butler, PA 16003-0910 (US)
Priority Data:
61/742,097 02.08.2012 US
Title (EN) POLYMER CONJUGATES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
(FR) CONJUGUÉS POLYMÈRES POUR L'ADMINISTRATION D'AGENTS BIOLOGIQUEMENT ACTIFS
Abstract: front page image
(EN)A delivery system for delivering oligonucleotides includes a conjugate includes a complexing agent including an oligonucleotide, a peptide nucleic acid or chimera thereof and a polymer covalently attached to the complexing agent. The complexing agent of the conjugate is adapted to complex a biologically active agent thereto after formation of the conjugate.
(FR)La présente invention concerne un système d'administration destiné à administrer des oligonucléotides. Ledit système comprend un conjugué incluant un agent complexant qui comporte un oligonucléotide, un acide nucléique peptidique ou sa chimère, et un polymère fixé par covalence audit agent complexant. Ledit agent complexant du conjugué est conçu pour former un complexe avec un agent biologiquement actif après la formation du conjugué.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)